Beijing News (Reporter Wang Kala) On April 27, during the 9th China Congress on Clinical Laboratory Science Technology and Application, Abbott launched its first enterprise-level diagnostic comprehensive solution — an end-to-end laboratory comprehensive solution. Relying on an efficient and intelligent combination of technologies, it aims to help Chinese medical institutions achieve a comprehensive upgrade in operational management and clinical diagnosis and treatment performance.
In recent years, China's medical market has experienced rapid growth, and the development of medical laboratories is facing numerous challenges. On one hand, with the implementation of various healthcare policies such as universal health insurance, tiered medical treatment, and chronic disease management, the volume of testing work has surged and demands have become increasingly diversified. On the other hand, the operational costs of medical institutions continue to rise, there is a shortage of laboratory personnel, and the existing one-size-fits-all medical laboratory solutions can no longer meet the high-load, complex diagnostic needs. Against this backdrop, building efficient and flexible intelligent medical laboratories to assist clinical departments in making reasonable and precise clinical decisions for patients has become a key focus and inevitable trend in the current development of China’s medical institutions.
Based on this, Abbott has launched a one-stop, personalized comprehensive solution for medical laboratories. This solution features a cohesive and coordinated testing system that enhances the overall testing efficiency of the laboratory in various aspects such as track loading capacity, track performance assurance, sample turnaround time, staff hands-off time, employee competency, and improvement in employee satisfaction. It achieves greater flexibility and adaptability while attaining operational excellence and sustainable development.
Proofread by Lu Qian